Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises
- PMID: 35568137
- PMCID: PMC10642301
- DOI: 10.1016/j.hrthm.2022.05.009
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises
Abstract
Background: TANGO2 deficiency disorder (TDD) is an autosomal recessive disease associated with metabolic crisis, lethal cardiac arrhythmias, and cardiomyopathy. Data regarding treatment, management, and outcomes of cardiac manifestations of TDD are lacking.
Objective: The purpose of this study was to describe TDD-related cardiac crises.
Methods: Retrospective multicenter chart review was made of TDD patients admitted with cardiac crises, defined as development of ventricular tachycardia (VT), cardiomyopathy, or cardiac arrest during metabolic crises.
Results: Twenty-seven children were admitted for 43 cardiac crises (median age 6.4 years; interquartile range [IQR] 2.4-9.8 years) at 14 centers. During crisis, QTc prolongation occurred in all (median 547 ms; IQR 504-600 ms) and a type I Brugada pattern in 8 (26%). Arrhythmias included VT in 21 (78%), supraventricular tachycardia in 3 (11%), and heart block in 1 (4%). Nineteen patients (70%) developed cardiomyopathy, and 20 (74%) experienced a cardiac arrest. There were 10 deaths (37%), 6 related to arrhythmias. In 5 patients, recalcitrant VT occurred despite use of antiarrhythmic drugs. In 6 patients, arrhythmias were controlled after extracorporeal membrane oxygenation (ECMO) support; 5 of these patients survived. Among 10 patients who survived VT without ECMO, successful treatment included intravenous magnesium, isoproterenol, and atrial pacing in multiple cases and verapamil in 1 patient. Initiation of feeds seemed to decrease VT events.
Conclusion: TDD-related cardiac crises are associated with a high risk of arrhythmias, cardiomyopathy, cardiac arrest, and death. Although further studies are needed, early recognition and appropriate treatment are critical. Acutely, intravenous magnesium, isoproterenol, atrial pacing, and ECMO as a last resort seem to be the best current treatment options, and early initiation of feeds may prevent VT events.
Keywords: Arrhythmia; Brugada syndrome; Cardiac arrest; Cardiomyopathy; Crisis; Death; Long QT syndrome; TANGO2; Treatment; Ventricular tachycardia.
Copyright © 2022. Published by Elsevier Inc.
Conflict of interest statement
Disclosures: The authors have no conflicts of interest to disclose.
Figures
Comment in
-
A dangerous dance: Recurrent cardiac crises in TANGO2-deficiency disorder.Heart Rhythm. 2022 Oct;19(10):1682-1683. doi: 10.1016/j.hrthm.2022.05.030. Epub 2022 May 28. Heart Rhythm. 2022. PMID: 35640786 No abstract available.
Similar articles
-
Folate as a potential treatment for lethal ventricular arrhythmias in TANGO2-deficiency disorder.JCI Insight. 2024 Jun 10;9(11):e171005. doi: 10.1172/jci.insight.171005. JCI Insight. 2024. PMID: 38855866 Free PMC article.
-
Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.Ann Acad Med Singap. 1998 Mar;27(2):248-54. Ann Acad Med Singap. 1998. PMID: 9663319 Review.
-
Cardiac arrhythmias in childhood. Diagnostic considerations and treatment.Drugs. 1991 Dec;42(6):974-83. doi: 10.2165/00003495-199142060-00006. Drugs. 1991. PMID: 1724643 Review.
-
Arrhythmias in the intensive care patient.Curr Opin Crit Care. 2003 Oct;9(5):345-55. doi: 10.1097/00075198-200310000-00003. Curr Opin Crit Care. 2003. PMID: 14508146 Review.
-
Arrhythmia-induced cardiomyopathy: A potentially reversible cause of refractory cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation.Heart Rhythm. 2021 Jul;18(7):1106-1112. doi: 10.1016/j.hrthm.2021.03.014. Epub 2021 Mar 12. Heart Rhythm. 2021. PMID: 33722763
Cited by
-
Defects in lipid homeostasis reflect the function of TANGO2 in phospholipid and neutral lipid metabolism.Elife. 2023 Mar 24;12:e85345. doi: 10.7554/eLife.85345. Elife. 2023. PMID: 36961129 Free PMC article.
-
TANGO2: A Rare but Important Mutation.J Innov Card Rhythm Manag. 2024 May 15;15(5):5871-5875. doi: 10.19102/icrm.2024.15054. eCollection 2024 May. J Innov Card Rhythm Manag. 2024. PMID: 38808169 Free PMC article.
-
Early initiation of B-vitamin supplementation may reduce symptoms and explain intrafamilial variability: Insights from two sibling pairs from the TANGO2 natural history study.Am J Med Genet A. 2023 Sep;191(9):2433-2439. doi: 10.1002/ajmg.a.63331. Epub 2023 Jul 8. Am J Med Genet A. 2023. PMID: 37421366 Free PMC article.
-
Multicenter appraisal of comorbid TANGO2 deficiency disorder in patients with 22q11.2 deletion syndrome.Am J Med Genet A. 2024 Oct;194(10):e63778. doi: 10.1002/ajmg.a.63778. Epub 2024 Jun 3. Am J Med Genet A. 2024. PMID: 38829177
-
Intrinsic and extrinsic regulation of rhabdomyolysis susceptibility by Tango2.Dis Model Mech. 2023 Sep 1;16(9):dmm050092. doi: 10.1242/dmm.050092. Epub 2023 Sep 5. Dis Model Mech. 2023. PMID: 37577943 Free PMC article.
References
-
- Berat CM, Montealegre S, Wiedemann A, et al. Clinical and biological characterization of 20 patients with TANGO2 deficiency indicates novel triggers of metabolic crises and no primary energetic defect. J Inherit Metab Dis 2021; 44:415–425. - PubMed
-
- Jennions E, Hedberg-Oldfors C, Berglund AK, et al. TANGO2 deficiency as a cause of neurodevelopmental delay with indirect effects on mitochondrial energy metabolism. J Inherit Metab Dis 2019;42:898–908. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
